Publications by authors named "Steven Watts"

Claim this Profile
S
Sub-setting systemic lupus erythematosus by combined molecular phenotypes defines divergent populations in two phase III randomized trials.
Michelle Petri, Steven D Watts, Richard E Higgs, Matthew D Linnik

Rheumatology (Oxford)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IUPACpal: efficient identification of inverted repeats in IUPAC-encoded DNA sequences.
Hayam Alamro, Mai Alzamel, Costas S Iliopoulos, Solon P Pissis, Steven Watts

BMC Bioinformatics· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
Kenneth C Kalunian, Murray B Urowitz, David Isenberg, Joan T Merrill, Michelle Petri, Steven Watts

Rheumatology (Oxford)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.
Gerald B Brock, Kevin T McVary, Claus G Roehrborn, Steven Watts, Xiao Ni

J Urol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tadalafil 5 mg once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: subgroup analyses of pooled data from 4 multinational, randomized, placebo-controlled clinical studies.
Hartmut Porst, Matthias Oelke, Evan R Goldfischer, David Cox, Steven Watts

Urology· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction.
Gregory A Broderick, Gerald B Brock, Claus G Roehrborn, Steven D Watts, Albert Elion-Mboussa

Urology· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Likelihood of tadalafil-associated adverse events in integrated multiclinical trial database: classification tree analysis in men with erectile dysfunction.
Gerald Brock, Sidney Glina, Ignacio Moncada, Steven Watts, Lei Xu

Urology· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option.
Craig F Donatucci, David G Wong, Francois Giuliano, Sidney Glina, Sherie A Dowsett, Steven Watts

Curr Med Res Opin· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study.
Wayne J G Hellstrom, Marc Gittelman, Jonathan Jarow, Christopher Steidle, James McMurray, Steven Watts

Eur Urol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction.
Ken Marumo, Takeshi Imaoka, Kenjiro Fujimoto, Steven Watts, Diane Stothard

J Sex Med· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tadalafil 5, 10, and 20 mg in Japanese men with erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled study.
Koichi Nagao, Yasusuke Kimoto, Ken Marumo, Akira Tsujimura, G Matthew Vail, Steven Watts

Urology· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
Elaine E Jolly, Nina H Bjarnason, Patrick Neven, Leo Plouffe, C Conrad Johnston, Steven D Watts

Menopause· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis